Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Debeb BG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-18 z 18
    Tytuł:
    NDRGs in Breast Cancer: A Review and In Silico Analysis.
    Autorzy:
    Villodre ES; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Nguyen APN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Debeb BG; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2024 Mar 29; Vol. 16 (7). Date of Electronic Publication: 2024 Mar 29.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Influence of Macrophages on Vascular Invasion of Inflammatory Breast Cancer Emboli Measured Using an In Vitro Microfluidic Multi-Cellular Platform.
    Autorzy:
    Gadde M; Walker Department of Mechanical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
    Mehrabi-Dehdezi M; Walker Department of Mechanical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
    Debeb BG; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Woodward WA; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Rylander MN; Walker Department of Mechanical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.; Oden Institute for Computational and Engineering Sciences, The University of Texas at Austin, Austin, TX 78712, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Oct 08; Vol. 15 (19). Date of Electronic Publication: 2023 Oct 08.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Inflammatory breast cancer appearance at presentation is associated with overall survival.
    Autorzy:
    Balema W; Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Radiation Oncology, Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Liu D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Shen Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    El-Zein R; Department of Radiology, Houston Methodist Cancer Center, Houston, TX, USA.
    Debeb BG; Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Kai M; Department of Radiation Oncology, Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Overmoyer B; Dana-Farber Cancer Institute, Boston, MA, USA.
    Miller KD; Indiana University School of Medicine, Indianapolis, IN, USA.
    Le-Petross HT; Department of Radiation Oncology, Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Ueno NT; Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Woodward WA; Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Department of Radiation Oncology, Morgan Welch IBC Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2021 Sep; Vol. 10 (18), pp. 6261-6272. Date of Electronic Publication: 2021 Jul 30.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast/*immunology
    Inflammatory Breast Neoplasms/*mortality
    Adult ; Aged ; Aged, 80 and over ; Breast/pathology ; Breast/surgery ; Chemotherapy, Adjuvant/methods ; Chemotherapy, Adjuvant/statistics & numerical data ; Female ; Humans ; Inflammatory Breast Neoplasms/diagnosis ; Inflammatory Breast Neoplasms/immunology ; Inflammatory Breast Neoplasms/therapy ; Kaplan-Meier Estimate ; Mastectomy ; Middle Aged ; Neoadjuvant Therapy/methods ; Neoadjuvant Therapy/statistics & numerical data ; Prognosis ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors.
    Autorzy:
    Santiago-Sánchez GS; Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.; Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Noriega-Rivera R; Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.; Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Hernández-O'Farrill E; Department of Pharmaceutical Sciences, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Valiyeva F; Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Quiñones-Diaz B; Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.; Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Villodre ES; Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
    Debeb BG; Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
    Rosado-Albacarys A; Department of General Sciences, Rio Piedras Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Vivas-Mejía PE; Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.; Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2021 Aug 10; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 10.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antineoplastic Agents/*therapeutic use
    Inflammatory Breast Neoplasms/*drug therapy
    Lipocalin-2/*antagonists & inhibitors
    Cell Line, Tumor ; Cell Movement/drug effects ; Cell Movement/genetics ; Cell Proliferation/drug effects ; Cell Proliferation/genetics ; Cell Survival/drug effects ; Cell Survival/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Inflammatory Breast Neoplasms/genetics ; Inflammatory Breast Neoplasms/pathology ; Lipocalin-2/genetics ; MCF-7 Cells ; Molecular Targeted Therapy/methods ; Neoplasm Invasiveness ; RNA, Small Interfering/pharmacology ; RNA, Small Interfering/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer.
    Autorzy:
    Hu X; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Villodre ES; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Larson R; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Rahal OM; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Wang X; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Gong Y; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Song J; Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Krishnamurthy S; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Ueno NT; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Tripathy D; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Woodward WA; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
    Debeb BG; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. .; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. .
    Pokaż więcej
    Źródło:
    Communications biology [Commun Biol] 2021 Jan 15; Vol. 4 (1), pp. 72. Date of Electronic Publication: 2021 Jan 15.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Decorin/*metabolism
    Inflammatory Breast Neoplasms/*metabolism
    Autophagy ; Cadherins/metabolism ; Carcinogenesis ; Cell Line, Tumor ; ErbB Receptors/metabolism ; Humans ; Neoplasm Metastasis ; Xenograft Model Antitumor Assays
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer.
    Autorzy:
    Villodre ES; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Gong Y; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Hu X; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Huo L; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Yoon EC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Woodward WA; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Debeb BG; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2020 Dec 10; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 10.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.
    Autorzy:
    Gagliardi M; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Pitner MK; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Park J; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Xie X; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Saso H; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Larson RA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Sammons RM; Division of Chemical Biology and Medicinal Chemistry, The University of Texas at Austin, College of Pharmacy, Austin, TX, USA.
    Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Wei C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Masuda H; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Breast Surgical Oncology, Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
    Chauhan G; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Kondo K; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Tripathy D; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Ueno NT; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Dalby KN; Division of Chemical Biology and Medicinal Chemistry, The University of Texas at Austin, College of Pharmacy, Austin, TX, USA.
    Debeb BG; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Bartholomeusz C; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 May 22; Vol. 10 (1), pp. 8537. Date of Electronic Publication: 2020 May 22.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Expression Regulation, Neoplastic*
    Biomarkers, Tumor/*metabolism
    Lung Neoplasms/*secondary
    Mitogen-Activated Protein Kinase 1/*metabolism
    Mitogen-Activated Protein Kinase 3/*metabolism
    Neoplastic Stem Cells/*pathology
    Triple Negative Breast Neoplasms/*pathology
    Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Movement ; Cell Proliferation ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/metabolism ; Mice ; Mice, SCID ; Mitogen-Activated Protein Kinase 1/antagonists & inhibitors ; Mitogen-Activated Protein Kinase 1/genetics ; Mitogen-Activated Protein Kinase 3/antagonists & inhibitors ; Mitogen-Activated Protein Kinase 3/genetics ; Neoplastic Stem Cells/metabolism ; Prognosis ; RNA, Small Interfering/genetics ; Survival Rate ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/metabolism ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
    Autorzy:
    Bambhroliya A; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States of America.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
    Van Wyhe RD; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Baylor College of Medicine, Houston, TX, United States of America.
    Kumar S; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States of America.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
    Debeb BG; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
    Reddy JP; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
    Van Laere S; Department of Oncology, the University of Antwerp, Antwerpen, Belgium.
    El-Zein R; Department of Radiology, Houston Methodist Hospital, Houston, TX, United States of America.
    Rao A; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
    Woodward WA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Apr 04; Vol. 13 (4), pp. e0192689. Date of Electronic Publication: 2018 Apr 04 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Expression Profiling*
    Gene Expression Regulation, Neoplastic*
    Inflammatory Breast Neoplasms/*etiology
    Inflammatory Breast Neoplasms/*genetics
    Triple Negative Breast Neoplasms/*etiology
    Triple Negative Breast Neoplasms/*genetics
    Animals ; Breast/metabolism ; Breast/physiopathology ; Breast Feeding ; Databases, Genetic ; Female ; Gene Ontology ; Humans ; Inflammatory Breast Neoplasms/physiopathology ; Lactation ; Mice ; Protective Factors ; Triple Negative Breast Neoplasms/physiopathology ; Weaning
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer.
    Autorzy:
    Caceres S; Department of Animal Physiology, Complutense University of Madrid (UCM), Madrid, Spain.
    Peña L; Department of Animal Medicine, Surgery and Pathology, School of Veterinary Medicine, Complutense University of Madrid (UCM), Madrid, Spain.
    Lacerda L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Illera MJ; Department of Animal Physiology, Complutense University of Madrid (UCM), Madrid, Spain.
    de Andres PJ; Department of Animal Medicine, Surgery and Pathology, School of Veterinary Medicine, Complutense University of Madrid (UCM), Madrid, Spain.
    Larson RA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Gao H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Debeb BG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Woodward WA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Illera JC; Department of Animal Physiology, Complutense University of Madrid (UCM), Madrid, Spain.
    Pokaż więcej
    Źródło:
    Veterinary and comparative oncology [Vet Comp Oncol] 2017 Sep; Vol. 15 (3), pp. 980-995. Date of Electronic Publication: 2016 May 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Mammary Neoplasms, Animal/*pathology
    Animals ; Blotting, Western/veterinary ; Cell Line, Tumor ; Cell Proliferation ; Disease Models, Animal ; Dogs ; Female ; Flow Cytometry/veterinary
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer.
    Autorzy:
    Debeb BG; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
    Smith DL; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
    Li L; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
    Larson R; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
    Xu W; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
    Woodward WA; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 Mar 12; Vol. 10 (3), pp. e0120719. Date of Electronic Publication: 2015 Mar 12 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*metabolism
    Carcinoma/*metabolism
    Inhibitor of Apoptosis Proteins/*metabolism
    Radiation Tolerance/*genetics
    Receptors, Estrogen/*metabolism
    Breast Neoplasms/genetics ; Carcinoma/genetics ; Cell Line, Tumor ; Databases, Nucleic Acid ; Female ; Gene Expression ; Humans ; Inhibitor of Apoptosis Proteins/genetics ; MCF-7 Cells ; Neoplasm Staging ; Paclitaxel/pharmacology ; Phosphorylation ; Radiation Tolerance/drug effects ; Survivin
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
    Autorzy:
    Zhang P; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Wei Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Wang L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Debeb BG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Yuan Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Zhang J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Yuan J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Wang M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Chen D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Sun Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Woodward WA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Liu Y; Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, Kentucky 40202, USA.
    Dean DC; Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, Kentucky 40202, USA.
    Liang H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Hu Y; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, USA.
    Ang KK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
    Hung MC; 1] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung 402, Taiwan [3] Cancer Biology Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.
    Chen J; 1] Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Cancer Biology Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.
    Ma L; 1] Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Cancer Biology Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.
    Pokaż więcej
    Źródło:
    Nature cell biology [Nat Cell Biol] 2014 Sep; Vol. 16 (9), pp. 864-75. Date of Electronic Publication: 2014 Aug 03.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    DNA Damage*
    Ataxia Telangiectasia Mutated Proteins/*physiology
    Breast Neoplasms/*metabolism
    Homeodomain Proteins/*metabolism
    Protein Kinases/*metabolism
    Transcription Factors/*metabolism
    Animals ; Breast Neoplasms/mortality ; Checkpoint Kinase 1 ; DNA Repair ; Epithelial-Mesenchymal Transition ; Female ; Gene Expression Regulation, Neoplastic ; HEK293 Cells ; HeLa Cells ; Homeodomain Proteins/genetics ; Humans ; Kaplan-Meier Estimate ; MCF-7 Cells ; Mice ; Mice, Nude ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Phosphorylation ; Protein Stability ; Radiation Tolerance ; Snail Family Transcription Factors ; Transcription Factors/genetics ; Twist-Related Protein 1/genetics ; Twist-Related Protein 1/metabolism ; Ubiquitin Thiolesterase/metabolism ; Ubiquitin-Specific Peptidase 7 ; Ubiquitination ; Up-Regulation ; Xenograft Model Antitumor Assays ; Zinc Finger E-box-Binding Homeobox 1
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
    Autorzy:
    Debeb BG; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
    Gong Y; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
    Atkinson RL; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
    Sneige N; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .
    Huo L; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
    Gonzalez-Angulo AM; Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .
    Hung MC; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. .
    Valero V; Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
    Ueno NT; Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
    Woodward WA; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. .; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .; Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1202, 77030, Houston, TX, USA. .
    Pokaż więcej
    Źródło:
    Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2014 Jul 23; Vol. 33, pp. 58. Date of Electronic Publication: 2014 Jul 23.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Neoplasm Recurrence, Local*
    Biomarkers, Tumor/*analysis
    Inflammatory Breast Neoplasms/*chemistry
    Inflammatory Breast Neoplasms/*radiotherapy
    Polycomb Repressive Complex 2/*analysis
    Triple Negative Breast Neoplasms/*chemistry
    Triple Negative Breast Neoplasms/*radiotherapy
    Adult ; Chi-Square Distribution ; Disease-Free Survival ; Enhancer of Zeste Homolog 2 Protein ; Female ; Humans ; Immunohistochemistry ; Inflammatory Breast Neoplasms/mortality ; Inflammatory Breast Neoplasms/pathology ; Kaplan-Meier Estimate ; Middle Aged ; Multivariate Analysis ; Predictive Value of Tests ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
    Autorzy:
    Anfossi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Giordano A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Gao H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Cohen EN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Tin S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Wu Q; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Garza RJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Debeb BG; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Alvarez RH; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Valero V; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Calin GA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Ueno NT; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Woodward WA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Jan 08; Vol. 9 (1), pp. e83113. Date of Electronic Publication: 2014 Jan 08 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Inflammatory Breast Neoplasms/*blood
    Inflammatory Breast Neoplasms/*genetics
    MicroRNAs/*blood
    Receptor, ErbB-2/*metabolism
    Case-Control Studies ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Inflammatory Breast Neoplasms/pathology ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
    Autorzy:
    Xu W; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Lacerda L
    Debeb BG
    Atkinson RL
    Solley TN
    Li L
    Orton D
    McMurray JS
    Hang BI
    Lee E
    Klopp AH
    Ueno NT
    Reuben JM
    Krishnamurthy S
    Woodward WA
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2013 Aug 27; Vol. 8 (8), pp. e71508. Date of Electronic Publication: 2013 Aug 27 (Print Publication: 2013).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antineoplastic Agents/*pharmacology
    Breast Neoplasms/*drug therapy
    Lung Neoplasms/*drug therapy
    Pyrvinium Compounds/*pharmacology
    Radiation-Sensitizing Agents/*pharmacology
    Animals ; Anthelmintics/pharmacology ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Survival/drug effects ; Down-Regulation/drug effects ; Epithelial-Mesenchymal Transition ; Female ; Humans ; Inhibitory Concentration 50 ; Lung Neoplasms/secondary ; Mice ; Mice, Nude ; Mice, SCID ; Neoplastic Stem Cells/drug effects ; Radiation Tolerance/drug effects ; Spheroids, Cellular/drug effects ; Spheroids, Cellular/physiology ; Wnt Signaling Pathway ; Xenograft Model Antitumor Assays ; beta Catenin/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro.
    Autorzy:
    Xu W; Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. .
    Debeb BG
    Lacerda L
    Li J
    Woodward WA
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2011 May 04; Vol. 3 (2), pp. 2274-85. Date of Electronic Publication: 2011 May 04.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
    Autorzy:
    Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
    Lacerda L
    Gupta A
    Debeb BG
    Solley T
    Li L
    Spaeth E
    Xu W
    Zhang X
    Lewis MT
    Reuben JM
    Krishnamurthy S
    Ferrari M
    Gaspar R
    Buchholz TA
    Cristofanilli M
    Marini F
    Andreeff M
    Woodward WA
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2010 Aug 16; Vol. 5 (8), pp. e12180. Date of Electronic Publication: 2010 Aug 16.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast/*cytology
    Breast/*pathology
    Breast Neoplasms/*pathology
    Cadherins/*metabolism
    Cell Culture Techniques/*methods
    Mesenchymal Stem Cells/*metabolism
    Animals ; Breast/metabolism ; Breast Neoplasms/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Transformation, Neoplastic ; Culture Media, Conditioned/pharmacology ; Gene Expression Regulation ; Humans ; Mammary Glands, Human/cytology ; Mammary Glands, Human/pathology ; Mice ; Neoplasm Metastasis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.
    Autorzy:
    Debeb BG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Zhang X
    Krishnamurthy S
    Gao H
    Cohen E
    Li L
    Rodriguez AA
    Landis MD
    Lucci A
    Ueno NT
    Robertson F
    Xu W
    Lacerda L
    Buchholz TA
    Cristofanilli M
    Reuben JM
    Lewis MT
    Woodward WA
    Pokaż więcej
    Źródło:
    Molecular cancer [Mol Cancer] 2010 Jul 08; Vol. 9, pp. 180. Date of Electronic Publication: 2010 Jul 08.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Kidney/*embryology
    Neoplasms/*pathology
    Neoplastic Stem Cells/*pathology
    Cell Line ; Culture Media, Serum-Free ; Humans ; Kidney/cytology ; MicroRNAs/genetics ; Neoplasm Metastasis/pathology ; Prospective Studies ; Up-Regulation
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines.
    Autorzy:
    Debeb BG; Department of Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
    Galat V
    Epple-Farmer J
    Iannaccone S
    Woodward WA
    Bader M
    Iannaccone P
    Binas B
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2009 Sep 28; Vol. 4 (9), pp. e7216. Date of Electronic Publication: 2009 Sep 28.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Expression Regulation*
    Endoderm/*cytology
    Octamer Transcription Factor-3/*metabolism
    Animals ; Cell Culture Techniques ; Cell Differentiation ; Cell Lineage ; Cell Separation ; Embryonic Stem Cells/cytology ; Endoderm/metabolism ; Female ; Flow Cytometry ; Male ; Mice ; Rats ; Transcription Factors/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-18 z 18

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies